The Report “Israel Bio-pharma Research Market (Product (Consumables-Assay, Kits and Reagent, Cell Line, Instrument (Separation, Imaging), Software, Services), (End User (Biotechnology/Bio-pharmaceutical Company CROs, Academic and Research institute)) - Forecast to 2020”, the Israel bio-pharma research market is estimated at $460.8 million in 2015, and is expected to reach $659.2 million by 2020, at a CAGR of 7.4% from 2015 to 2020.
Browse through the TOC of the Israel Bio-pharma Research Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report
Israel is home to some of world's leading research institutes, and R&D facilities in the biopharmaceutical sector. Owing to its innovation-driven economy, highly skilled workforce, and sufficient funding, Israel is among the leading innovators in biopharmaceutical R&D. The factors such as the increasing number of pharmaceutical and biotechnology start-ups, government support, availability of sufficient venture capital (VC) funds, and availability of skilled, educated, and diverse workforce are likely to drive the market. However, government regulations (such as drug pricing) are the major factors restraining the growth of this market. On the other hand, the academia-industry partnerships and mergers & acquisitions among biopharmaceutical players offer lucrative growth opportunities in this market.
The Israel bio-pharma research market is broadly segmented on the basis of products & services and end user. On the basis of products and services, the Israel bio-pharma research market is segmented into instruments, consumables, bioreactors, services, and software. The consumables market is expected to account for the largest share of the Israel bio-pharma research market in 2015. However, the software market is expected to witness the highest growth during the forecast period, owing to the advancements in bioinformatics tools.
Based on end users, the market is sub segmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for the largest share of the Israel bio-pharma research market in 2015. The largest share is attributed to factors such as the technological advancements, increased investments from governments, and private companies.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
